Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio‚Äôs strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.

Gossamer Bio

Clinical Trial Associate

Clinical Trial Associate/Senior Clinical Trial Associate

4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

4D Molecular Therapeutics is a biotechnology company.The Company designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

4D Molecular Therapeutics

Sr. Clinical Trial Associate

Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders.

Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders caused by nucleotide repeat expansions. The companyâ€™s lead program is focused on the treatment of Friedreichâ€™s ataxia and discovery efforts are ongoing in other degenerative diseases.

Design Therapeutics

Inflammatix develops novel molecular diagnostics for acute infections and sepsis that work by reading the immune system.

Inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by 'reading' the immune system. It is a molecular diagnostics company developing rapid tests that read the immune system to resolve major clinical and public health challenges. They are initially focused on developing tests for acute bacterial and viral infections, and sepsis based on patent-pending biomarkers exclusively licensed from Stanford University. The company was founded by Timothy Sweeney and Jonathan Romanowsky in California.

Inflammatix

Senior Clinical Trial Associate

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor for treatment of severe allergy and inflammation. KIT is a cell surface receptor that acts as the master survival and functional regulator of mast cells, which are immune cells concentrated at the bodyâ€™s interfaces with the external environment and that act as the key mediator of the inflammation associated with allergic diseases.

Third Harmonic Bio

Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.

Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.  Its investigational product candidate, IMVT-1401 (formerly known as RVT-1401), is a novel, fully human monoclonal antibody targeting the neonatal Fc receptor (FcRn). We believe that this product has the potential to address a variety of IgG-mediated autoimmune diseases as a subcutaneous injection.

Immunovant

Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.

Thrive is a healthcare company focused on saving lives by making earlier detection of cancer a routine part of medical care. It develops CancerSEEK, a liquid biopsy test that is designed to detect many cancers at earlier stages of the disease. CancerSEEK will serve as the core of Thrive‚Äôs integrated cancer information offering. The company was launched in 2019 by Third Rock Ventures, with funding from additional investors Section 32, Casdin Capital, Biomatics Capital, BlueCross BlueShield Venture Partners, The Invus Group, Camden Partners Nexus, Cowin Venture, Exact Sciences, and Gamma3.

Thrive Earlier Detection

Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.

Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers by exploiting unique insights into chromosomal instability

Volastra Therapeutics

Axsome Therapeutics develops and commercializes therapies for the management and treatment of pain and other neurological disorders.

Axsome Therapeutics is a biopharmaceutical company developing novel therapies for the treatment of pain and other neurological diseases. By focusing on this therapeutic area, Axsome is addressing growing markets where current treatment options are limited or inadequate. Axsome has a balanced portfolio of clinical development stage as well as research stage products. Axsome Therapeutics aims to become a fully integrated biopharmaceutical company that develops and commercializes differentiated products which increase the armamentarium of caregivers and improve the lives of patients. While the focus of the company is on developing its internally derived product candidates, Axsome also evaluates potential in-licensing opportunities to supplement its current portfolio.

Location

Company Stage

Age of Data

Experience

Industry

Company

Clinical Trial Associate

Gossamer Bio

$84k - $127k

$84,000 - $127,400

4D Molecular Therapeutics

$85k - $120k

$85,000 - $120,000

Design Therapeutics

$70k - $120k

$70,000 - $120,000

Inflammatix

$88k - $105k

$88,000 - $105,000

Third Harmonic Bio

$77k - $89k

$77,000 - $89,000

Immunovant

$65k - $86k

$65,082 - $86,144

Thrive Earlier Detection

$51k - $81k

$51,000 - $81,000

Volastra Therapeutics

$45k - $75k

$45,000 - $75,000

Axsome Therapeutics

$60k - $66k

$60,000 - $66,000